Thursday, September 16, 2021

September 16, 2021 at 07:09PM Berinert

Product approval information is indicated for treatment of acute abdominal or facial attacks of hereditary angioedema (HAE) in adult and adolescent patients.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3hEduAd

No comments:

Post a Comment